Thyroid hormone action in the heart.

The heart is a major target organ for thyroid hormone action, and marked changes occur in cardiac function in patients with hypo- or hyperthyroidism. T(3)-induced changes in cardiac function can result from direct or indirect T(3) effects. Direct effects result from T(3) action in the heart itself and are mediated by nuclear or extranuclear mechanisms. Extranuclear T(3) effects, which occur independent of nuclear T(3) receptor binding and increases in protein synthesis, influence primarily the transport of amino acids, sugars, and calcium across the cell membrane. Nuclear T(3) effects are mediated by the binding of T(3) to specific nuclear receptor proteins, which results in increased transcription of T(3)-responsive cardiac genes. The T(3) receptor is a member of the ligand-activated transcription factor family and is encoded by cellular erythroblastosis A (c-erb A) genes. T(3) also leads to an increase in the speed of diastolic relaxation, which is caused by the more efficient pumping of the calcium ATPase of the sarcoplasmic reticulum. This T(3) effect results from T(3)-induced increases in the level of the mRNA coding for the sarcoplasmic reticulum calcium ATPase protein, leading to an increased number of calcium ATPase pump units in the sarcoplasmic reticulum.

[1]  F. B. Davis,et al.  Nongenomic actions of thyroid hormone on the heart. , 2002, Thyroid : official journal of the American Thyroid Association.

[2]  W. Dillmann Cellular action of thyroid hormone on the heart. , 2002, Thyroid : official journal of the American Thyroid Association.

[3]  D. Cooper,et al.  L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. , 1984, Annals of internal medicine.

[4]  M. Bilsker,et al.  Evidence of hyperthyroidism in apparently euthyroid patients treated with levothyroxine. , 1989, Archives of internal medicine.

[5]  F I Gilbert,et al.  Graves' Disease: Influence of Age on Clinical Findings , 1988 .

[6]  R. Hart,et al.  Thyrotoxicosis, atrial fibrillation, and embolism, revisited. , 1989, American heart journal.

[7]  A. Toft,et al.  Left ventricular performance in subclinical hypothyroidism. , 1985, The Quarterly journal of medicine.

[8]  J. Papp,et al.  The effect of altered thyroid state on atrial intracellular potentials , 1970, The Journal of physiology.

[9]  S. Nekolla,et al.  Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging. , 2000, The Journal of clinical endocrinology and metabolism.

[10]  B. Biondi,et al.  Cardiac Effects of Long Term Thyrotropin-Suppressive Therapy with Levothyroxine* , 1993 .

[11]  B. Nadal-Ginard,et al.  Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated. , 1984, The Journal of biological chemistry.

[12]  S. Cheng,et al.  Expression of the mutant thyroid hormone receptor PV in the pituitary of transgenic mice leads to weight reduction. , 1999, Thyroid : official journal of the American Thyroid Association.

[13]  M. Lazar,et al.  Widespread distribution of immunoreactive thyroid hormone beta 2 receptor (TR beta 2) in the nuclei of extrapituitary rat tissues. , 1994, The Journal of biological chemistry.

[14]  W. Wiersinga,et al.  Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. , 1991, The American journal of medicine.

[15]  J. Samarut,et al.  Genetic Analysis Reveals Different Functions for the Products of the Thyroid Hormone Receptor α Locus , 2001, Molecular and Cellular Biology.

[16]  Johan Malm,et al.  Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  E. Kranias,et al.  Thyroid hormone regulation of calcium cycling proteins. , 2002, Thyroid : official journal of the American Thyroid Association.

[18]  M. Aumont,et al.  Separation of muscle and non-muscle cells from adult rat myocardium: an application to the study of RNA polymerase. , 1977, Journal of molecular and cellular cardiology.

[19]  L. Braverman,et al.  Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text , 1991 .

[20]  A. Weyman,et al.  Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. , 1989, The New England journal of medicine.

[21]  I. Klein,et al.  Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. , 1986, The Journal of clinical investigation.

[22]  A. Uprichard,et al.  Hypothyroidism Renders Protection Against Lethal Ventricular Arrhythmias in a Conscious Canine Model of Sudden Death , 1991, Journal of cardiovascular pharmacology.

[23]  H. Nakazawa,et al.  Hyperthyroidism and the management of atrial fibrillation. , 2002, Thyroid : official journal of the American Thyroid Association.

[24]  B. Vennström,et al.  Evidence that decreased heart rate in thyroid hormone receptor-α1-deficient mice is an intrinsic defect. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[25]  E. Morkin Regulation of Myosin Heavy Chain Genes in the Heart , 1993, Circulation.

[26]  H. Seo,et al.  Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor beta-deficient mice. , 1998, Endocrinology.

[27]  J. Marshall,et al.  Action of thyroid hormone on the transmembrane potentials from sinoatrial node cells and atrial muscle cells in isolated atria of rabbits. , 1973, Cardiology.

[28]  J. Lingrel,et al.  Thyroid and glucocorticoid hormones regulate the expression of multiple Na,K-ATPase genes in cultured neonatal rat cardiac myocytes. , 1990, The Journal of biological chemistry.

[29]  P. Agostoni,et al.  Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy. , 1996, The American journal of medicine.

[30]  M. Lazar Thyroid hormone receptors: multiple forms, multiple possibilities. , 1993, Endocrine reviews.

[31]  S. Homma,et al.  A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. , 1999, The Journal of thoracic and cardiovascular surgery.

[32]  I. Klein,et al.  Thyroid hormone and blood pressure regulation , 2003, Current hypertension reports.

[33]  B. Gloss,et al.  Cardiac Expression and Function of Thyroid Hormone Receptor β and Its PV Mutant , 2003 .

[34]  J. Franklyn,et al.  Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study , 2001, The Lancet.

[35]  P. Ladenson,et al.  Complications of surgery in hypothyroid patients. , 1984, The American journal of medicine.

[36]  J. Davey,et al.  Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. , 1996, The Journal of clinical investigation.

[37]  K. Kamiya,et al.  Evidences of antagonism between amiodarone and triiodothyronine on the K+ channel activities of cultured rat cardiomyocytes. , 1997, Journal of molecular and cellular cardiology.

[38]  Harold Ridley,et al.  Eye Disease , 1967 .

[39]  R. Westendorp,et al.  Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies , 1996, Clinical endocrinology.

[40]  T. Agner,et al.  A reevaluation of atrial fibrillation in thyrotoxicosis. , 1984, Danish medical bulletin.

[41]  K. Knowlton,et al.  α1-Adrenergic Stimulation Inhibits 3,5,3'-Triiodothyronine-Induced Expression of the Rat Heart Sarcoplasmic Reticulum Ca2+ Adenosine Triphosphatase Gene1. , 1997, Endocrinology.

[42]  P. Nicod,et al.  The Thyroid and the Heart , 1993, Circulation.

[43]  D. Rodbard,et al.  Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism. , 1981, The Journal of clinical endocrinology and metabolism.

[44]  Van Gilst,et al.  The effects of bradykinin and the ischemic isolated rat heart. , 1990, Hormone and metabolic research. Supplement series.

[45]  Kornél Simon Mortality in elderly patients with subclinical hyperthyroidism , 2002, The Lancet.

[46]  G. Kahaly,et al.  Impaired cardiopulmonary exercise capacity in patients with hyperthyroidism. , 1996, Chest.

[47]  W. Dillmann Editorial: thyroid hormone action and cardiac contractility - a complex affair. , 1996, Endocrinology.

[48]  F. Saksena,et al.  Myocardial infarction associated with thyrotoxicosis. , 1977, Chest.

[49]  S. Liggett,et al.  Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons. , 1997, Circulation.

[50]  T. Osborne,et al.  Thyroid Hormone Regulation and Cholesterol Metabolism Are Connected through Sterol Regulatory Element-binding Protein-2 (SREBP-2)* , 2003, Journal of Biological Chemistry.

[51]  C. Reggiani,et al.  Maximum speed of shortening and ATPase activity in atrial and ventricular myocardia of hyperthyroid rats. , 1995, The American journal of physiology.

[52]  G. Hommel,et al.  Ineffective cardiorespiratory function in hyperthyroidism. , 1998, The Journal of clinical endocrinology and metabolism.

[53]  M. Surks,et al.  Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine. , 1998, The Journal of clinical endocrinology and metabolism.

[54]  T. Parkin,et al.  Treatment of heart disease associated with myxedema. , 1961, Progress in cardiovascular diseases.

[55]  S. Bahouth Thyroid hormones transcriptionally regulate the beta 1-adrenergic receptor gene in cultured ventricular myocytes. , 1991, The Journal of biological chemistry.

[56]  N. Davidson,et al.  Apolipoprotein B mRNA editing is modulated by thyroid hormone analogs but not growth hormone administration in the rat. , 1990, Molecular endocrinology.

[57]  M. Eghbali,et al.  Decreased collagen gene expression and absence of fibrosis in thyroid hormone-induced myocardial hypertrophy. Response of cardiac fibroblasts to thyroid hormone in vitro. , 1992, Circulation research.

[58]  W. Giles,et al.  Cardiac Ion Channel Expression and Contractile Function in Mice with Deletion of Thyroid Hormone Receptor α or β1 , 2001 .

[59]  G. Stiles,et al.  Thyroid hormone modulation of agonist--beta-adrenergic receptor interactions in the rat heart. , 1981, Life sciences.

[60]  P. Ladenson,et al.  Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[61]  D. Rohrer,et al.  Influence of thyroid hormone and retinoic acid on slow sarcoplasmic reticulum Ca2+ ATPase and myosin heavy chain alpha gene expression in cardiac myocytes. Delineation of cis-active DNA elements that confer responsiveness to thyroid hormone but not to retinoic acid. , 1991, The Journal of biological chemistry.

[62]  A. Steinberg Myxedema and coronary artery disease--a comparative autopsy study. , 1968, Annals of internal medicine.

[63]  O. Brodde Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. , 1991, Pharmacological reviews.

[64]  Robert W. Anderson,et al.  Cardiovascular Effects of Intravenous Triiodothyronine in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Randomized, Double-blind, Placebo-Controlled Trial , 1996 .

[65]  F. B. Davis,et al.  Rabbit myocardial membrane Ca2+-adenosine triphosphatase activity: stimulation in vitro by thyroid hormone. , 1984, Archives of biochemistry and biophysics.

[66]  J. Franklyn,et al.  Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. , 1996, Heart.

[67]  J. Lekakis,et al.  Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. , 1997, Thyroid : official journal of the American Thyroid Association.

[68]  D. Moore,et al.  Interaction of thyroid-hormone receptor with a conserved transcriptional mediator , 1995, Nature.

[69]  P. Hall,et al.  Mortality in patients treated for hyperthyroidism with iodine-131. , 1993, Acta endocrinologica.

[70]  A. Malcolm Mitral valve prolapse associated with other disorders. Casual coincidence, common link, or fundamental genetic disturbance? , 1985, British heart journal.

[71]  J. Segal Calcium is the first messenger for the action of thyroid hormone at the level of the plasma membrane: first evidence for an acute effect of thyroid hormone on calcium uptake in the heart. , 1990, Endocrinology.

[72]  B. Biondi,et al.  Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. , 1994, The Journal of clinical endocrinology and metabolism.

[73]  J. Segal Acute effect of thyroid hormone on the heart: an extranuclear increase in sugar uptake. , 1989, Journal of molecular and cellular cardiology.

[74]  H. Smulyan,et al.  Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. , 1988, Hypertension.

[75]  A. Toft,et al.  Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy. , 1982, The New England journal of medicine.

[76]  S. Thomas,et al.  Thyroid hormone treatment after coronary-artery bypass surgery. , 1995, The New England journal of medicine.

[77]  K. Nakao,et al.  Cardiomyopathy associated with Graves' disease , 1996, Clinical endocrinology.

[78]  B. Biondi,et al.  Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. , 2000, The Journal of clinical endocrinology and metabolism.

[79]  Toft Ad Clinical practice. Subclinical hyperthyroidism. , 2001, The New England journal of medicine.

[80]  H. Beug,et al.  The c-erb-A protein is a high-affinity receptor for thyroid hormone , 1986, Nature.

[81]  R. Monson,et al.  Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women. , 1988, American journal of epidemiology.

[82]  S. Goldman,et al.  Pilot Studies on the Use of 3,5-Diiodothyropropionic Acid, a Thyroid Hormone Analog, in the Treatment of Congestive Heart Failure , 2002, Cardiology.

[83]  K. Harjai,et al.  Effects of Amiodarone on Thyroid Function , 1997, Annals of Internal Medicine.

[84]  T. Abe,et al.  Thyroid hormone transporters: recent advances , 2002, Trends in Endocrinology & Metabolism.

[85]  K. Mall,et al.  TRANSIENT HYPOTENSION AFTER ANÆSTHESIA OF PERITONEUM , 1974 .

[86]  P. Ladenson,et al.  Modulation of myocardial L-triiodothyronine receptors in normal, hypothyroid, and hyperthyroid rats. , 1986, Metabolism: clinical and experimental.

[87]  M. Salvatore,et al.  Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. , 1996, The Journal of clinical endocrinology and metabolism.

[88]  W. Wiersinga,et al.  Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients. , 2001, European journal of endocrinology.

[89]  Shih‐Ann Chen,et al.  Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. , 2002, Journal of the American College of Cardiology.

[90]  A. Tajik,et al.  Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients. , 1985, The New England journal of medicine.

[91]  E. Park,et al.  Thyroid hormone induces beta1-adrenergic receptor gene transcription through a direct repeat separated by five nucleotides. , 1997, Journal of molecular and cellular cardiology.

[92]  B. Biondi,et al.  Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. , 2002, The Journal of clinical endocrinology and metabolism.

[93]  R. Riemersma,et al.  END‐ORGAN RESPONSES TO THYROXINE THERAPY IN SUBCLINICAL HYPOTHYROIDISM , 1985, Clinical endocrinology.

[94]  M. Bentivoglio,et al.  The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients. , 1988, Archives of internal medicine.

[95]  J. Ménard,et al.  Differences in the Signs and Symptoms of Hyperthyroidism in Older and Younger Patients , 1996, Journal of the American Geriatrics Society.

[96]  I. Klein,et al.  Thyroid hormone therapy in cardiovascular disease. , 1996, Progress in cardiovascular diseases.

[97]  Arterial embolism in thyrotoxicosis with atrial fibrillation. , 1981, Archives of internal medicine.

[98]  T. Ryan,et al.  Stress echocardiography in hyperthyroidism. , 1999, The Journal of clinical endocrinology and metabolism.

[99]  G. Kahaly,et al.  HPLC glycosaminoglycan analysis in patients with Graves' disease. , 1997, Clinical science.

[100]  I. Klein,et al.  Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes. , 2000, American journal of physiology. Endocrinology and metabolism.

[101]  S. Goldman,et al.  Control of cardiac output in thyrotoxic calves. Evaluation of changes in the systemic circulation. , 1984, The Journal of clinical investigation.

[102]  J. Harney,et al.  Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. , 1996, Endocrinology.

[103]  G. Kahaly,et al.  Left ventricular function analyzed by Doppler and echocardiographic methods in short-term hypothyroidism. , 1995, The American journal of cardiology.

[104]  P. Ladenson Thyrotoxicosis and the heart: something old and something new. , 1993, The Journal of clinical endocrinology and metabolism.

[105]  A. Toft,et al.  Left ventricular function in hypothyroidism. Responses to exercise and beta adrenoceptor blockade. , 1982, British heart journal.

[106]  G. Kahaly,et al.  Cardiac risks of hyperthyroidism in the elderly. , 1998, Thyroid : official journal of the American Thyroid Association.

[107]  I. Klein,et al.  Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. , 1991, The Journal of clinical endocrinology and metabolism.

[108]  A. Hofman,et al.  Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study , 2000, Annals of Internal Medicine.

[109]  I. Klein,et al.  Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac beta-adrenergic receptor responsiveness. , 2000, Metabolism: clinical and experimental.

[110]  L. Friberg,et al.  Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina? , 2002, Archives of internal medicine.

[111]  R. Erbel,et al.  Cardiac arrhythmias and heart rate in hyperthyroidism. , 1989, The American journal of cardiology.

[112]  G. Williams,et al.  Mechanism of thyroid hormone action. , 2002, Thyroid : official journal of the American Thyroid Association.

[113]  E. Liberti,et al.  Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[114]  B. Biondi,et al.  Impact of Hyperthyroidism and Its Correction on Vascular Reactivity in Humans , 2001, Circulation.

[115]  A. Burden,et al.  REVERSIBLE HYPERTENSION AND HYPOTHYROIDISM , 1980, Clinical endocrinology.

[116]  G. Riegger,et al.  Characteristics and clinical relevance of animal models of heart failure. , 1995, Current opinion in cardiology.

[117]  I. Klein,et al.  Usefulness of triiodothyronine (T3) treatment after surgery for complex congenital heart disease in infants and children. , 1999, The American journal of cardiology.

[118]  M. Luu,et al.  Altered thyroid hormone metabolism in advanced heart failure. , 1990, Journal of the American College of Cardiology.

[119]  R. Childers,et al.  Atrial Electrophysiology in Experimental Hyperthyroidism in Rabbits , 1970, Circulation research.

[120]  G. Brierley,et al.  Hyperthyroid adult rat cardiomyocytes. I. Nucleotide content, beta- and alpha-adrenoreceptors, and cAMP production. , 1989, The American journal of physiology.

[121]  G. Kahaly,et al.  Glycosaminoglycans in thyroid eye disease. , 1998, Thyroid : official journal of the American Thyroid Association.

[122]  A. Samarel,et al.  Thyroid hormone effects on cardiac gene expression independent of cardiac growth and protein synthesis. , 1992, The American journal of physiology.

[123]  P. Ladenson,et al.  Augmented hepatic and skeletal thyromimetic effects of tiratricol in comparison with levothyroxine. , 1997, The Journal of clinical endocrinology and metabolism.

[124]  I. Klein,et al.  Acute effects of thyroid hormone on vascular smooth muscle. , 1996, Thyroid : official journal of the American Thyroid Association.

[125]  J. Viikari,et al.  Dupuytren's disease in type 1 diabetic patients: a five-year prospective study. , 1996, Clinical and experimental rheumatology.

[126]  Karl H. Pribram,et al.  Functions of the , 1954 .

[127]  B. Biondi,et al.  Effects of thyroid hormone on the cardiovascular system. , 2004, Recent progress in hormone research.

[128]  Y. Shimoni,et al.  Thyroxine effects on temperature dependence of ionic currents in single rabbit cardiac myocytes. , 1993, The American journal of physiology.

[129]  I. Klein,et al.  Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. , 1996, The Annals of thoracic surgery.

[130]  R. Baggott DISEASE , 1947, Social Policy & Administration.

[131]  N. Takasu [Thyroid hormone and the cardiovascular system]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[132]  D. Lawson,et al.  Death from thyrotoxicosis. , 1973, Lancet.

[133]  S. Schiaffino,et al.  Myosin Types in the Human Heart: An Immunofluorescence Study of Normal and Hypertrophied Atrial and Ventricular Myocardium , 1984, Circulation research.

[134]  H. Lindberg,et al.  DEPRESSED THYROID FUNCTION FOLLOWING PAEDIATRIC RELEASE? CARDIOPULMONARY BYPASS: ASSOCIATION WITH INTERLEUKIN-6 , 1996 .

[135]  P. Petersen,et al.  Stroke in thyrotoxicosis with atrial fibrillation. , 1988, Stroke.

[136]  C. Dehay,et al.  The T3Rα gene encoding a thyroid hormone receptor is essential for post‐natal development and thyroid hormone production , 1997, The EMBO journal.

[137]  G. Kahaly,et al.  Increased sulfatation of orbital glycosaminoglycans in Graves' ophthalmopathy. , 1999, The Journal of clinical endocrinology and metabolism.

[138]  M. Surks,et al.  Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin-suppressive doses of L-thyroxine. , 1997, The Journal of clinical endocrinology and metabolism.

[139]  T. Aizawa,et al.  Echocardiographic studies on the relationship between atrial fibrillation and atrial enlargement in patients with hyperthyroidism of Graves' disease. , 1989, Cardiology.

[140]  W Craelius,et al.  Acute effects of thyroid hormone analogs on sodium currents in neonatal rat myocytes. , 1999, Journal of molecular and cellular cardiology.

[141]  D. Severson,et al.  Thyroid status and potassium currents in rat ventricular myocytes. , 1995, The American journal of physiology.

[142]  A. Weetman,et al.  Pharmacotherapeutics of the Thyroid Gland , 1997, Handbook of Experimental Pharmacology.

[143]  G. Daniels Amiodarone-induced thyrotoxicosis. , 2001, The Journal of clinical endocrinology and metabolism.

[144]  J. Franklyn,et al.  Hyperthyroidism and cardiovascular morbidity and mortality. , 2002, Thyroid : official journal of the American Thyroid Association.

[145]  J. Spann,et al.  Hyperthyroidism and mitral-valve prolapse. , 1981, The New England journal of medicine.

[146]  Y. Tomizawa,et al.  Right ventricular dynamics during left ventricular assistance in closed-chest dogs. , 1993, The Annals of thoracic surgery.

[147]  D. Moliterno,et al.  Case report: coronary vasospasm--relation to the hyperthyroid state. , 1992, The American journal of the medical sciences.

[148]  J. Selby The Thyroid: A Fundamental and Clinical Text , 1992 .

[149]  V. Laudet,et al.  Identification of Transcripts Initiated from an Internal Promoter in the c-erbAα Locus That Encode Inhibitors of Retinoic Acid Receptor-α and Triiodothyronine Receptor Activities , 1997 .

[150]  D. Pehowich Hypothyroid state and membrane fatty acid composition influence cardiac mitochondrial pyruvate oxidation. , 1995, Biochimica et biophysica acta.

[151]  P. Webb,et al.  Triiodothyronine Increases Brain Natriuretic Peptide (BNP) Gene Transcription and Amplifies Endothelin-dependent BNP Gene Transcription and Hypertrophy in Neonatal Rat Ventricular Myocytes* , 2003, The Journal of Biological Chemistry.

[152]  P. Ladenson Recognition and management of cardiovascular disease related to thyroid dysfunction. , 1990, The American journal of medicine.

[153]  S. Goldman,et al.  Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure. , 2002, Thyroid : official journal of the American Thyroid Association.

[154]  R. E. Clark Cardiopulmonary bypass and thyroid hormone metabolism. , 1993, The Annals of thoracic surgery.

[155]  N. Alpert,et al.  Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins. , 1991, Circulation research.

[156]  S. Goldman,et al.  Studies on the use of thyroid hormone and a thyroid hormone analogue in the treatment of congestive heart failure. , 1993, The Annals of thoracic surgery.

[157]  S. Incerpi,et al.  Short-Term Effects of Thyroid Hormones on the Na/H Antiport in L-6 Myoblasts: High Molecular Specificity for 3,3′,5-Triiodo-l-Thyronine , 1999 .

[158]  G. Callas,et al.  Alterations in the fine structure of cardiac muscle mitochondria induced by hyperthyroidism , 1974, The Anatomical record.

[159]  L. Ghiadoni,et al.  Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. , 2003, The Journal of clinical endocrinology and metabolism.

[160]  T. Visser,et al.  Uptake of thyroid hormones in neonatal rat cardiac myocytes. , 1996, Endocrinology.

[161]  D. Iannone [The cardiovascular system in hypothyroidism]. , 1967, Il Policlinico. Sezione pratica.

[162]  D. Cooper Clinical practice. Subclinical hypothyroidism. , 2001, The New England journal of medicine.

[163]  C. Kirkegaard,et al.  Hyperthyroidism—a Disease of Old Age? , 1973, British medical journal.

[164]  J. Campbell,et al.  A correlation of clinical and hemodynamic studies in patients with hyperthyroidism with and without congestive heart failure. , 1959, The Journal of clinical investigation.

[165]  K. Kamiya,et al.  Cellular electropharmacology of amiodarone. , 1997, Cardiovascular research.

[166]  Á. Zarain-Herzberg,et al.  Thyroid hormone receptor modulates the expression of the rabbit cardiac sarco (endo) plasmic reticulum Ca(2+)-ATPase gene. , 1994, The Journal of biological chemistry.

[167]  J. Chiang,et al.  Effect of thyroid hormone on hepatic cholesterol 7 alpha hydroxylase, LDL receptor, HMG-CoA reductase, farnesyl pyrophosphate synthetase and apolipoprotein A-I mRNA levels in hypophysectomized rats. , 1990, Biochemical and biophysical research communications.

[168]  N. Zuhdi,et al.  Triiodothyronine as an inotropic agent after open heart surgery. , 1989, The Journal of thoracic and cardiovascular surgery.

[169]  Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. , 1999, The Journal of clinical endocrinology and metabolism.

[170]  Outcome of percutaneous transluminal coronary angioplasty in patients with subclinical hypothyroidism. , 1995, Thyroid : official journal of the American Thyroid Association.

[171]  R. Stravitz,et al.  Hormonal regulation of cholesterol 7alpha-hydroxylase specific activity, mRNA levels, and transcriptional activity in vivo in the rat. , 1997, Journal of lipid research.

[172]  G. Kahaly,et al.  [Cardiovascular effects of thyroid hormones]. , 1996, Zeitschrift fur Kardiologie.

[173]  C. Gorman,et al.  L‐Thyroxine contamination of pharmaceutical D‐thyroxine: Probable cause of therapeutic effect , 1984, Clinical pharmacology and therapeutics.

[174]  L. Dieckman,et al.  Effect of thyroid status on thin-filament Ca2+ regulation and expression of troponin I in perinatal and adult rat hearts. , 1990, Circulation research.

[175]  A. Sugawara,et al.  Phosphorylation selectively increases triiodothyronine receptor homodimer binding to DNA. , 1994, The Journal of biological chemistry.

[176]  P. Nicod,et al.  Effect of thyroid replacement therapy on the frequency of benign atrial and ventricular arrhythmias. , 1989, Journal of the American College of Cardiology.

[177]  P. Ladenson,et al.  Percutaneous transluminal coronary angioplasty in hypothyroidism. , 1991, The American journal of medicine.

[178]  S. Izumo,et al.  Thyroid hormone receptor α isoforms generated by alternative splicing differentially activate myosin HC gene transcription , 1988, Nature.

[179]  R. Mainwaring,et al.  Pharmacokinetic evaluation of triiodothyronine supplementation in children after modified Fontan procedure. , 2000, Circulation.

[180]  L. Braitman,et al.  Chronic thyroiditis and mitral valve prolapse. , 1985, Annals of internal medicine.

[181]  I. Klein,et al.  Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. , 1990, The American journal of medicine.

[182]  T. Lynn The cardiovascular system in thyrotoxicosis. , 1961, The Journal of the Oklahoma State Medical Association.

[183]  J. Bilezikian,et al.  The Influence of Hyperthyroidism and Hypothyroidism on α and β-Adrenergic Receptor Systems and Adrenergic Responsiveness* , 1983 .

[184]  I. Klein,et al.  Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. , 2000, Endocrinology.

[185]  J. Dussault,et al.  Plasma catecholamine concentrations in hyperthyroidism and hypothyroidism. , 1976, Metabolism: clinical and experimental.

[186]  C. Baumgarten,et al.  Bursting of cardiac sodium channels after acute exposure to 3,5,3'-triiodo-L-thyronine. , 1993, Circulation research.

[187]  B. Gilbert,et al.  Concurrent aortic and mitral valve echocardiography permits measurement of systolic time intervals as an index of peripheral tissue thyroid functional status. , 1989, The Journal of clinical endocrinology and metabolism.

[188]  E. O. Theilen,et al.  Hemodynamic effects of peripheral vasoconstriction in normal and thyrotoxic subjects. , 1967, Journal of applied physiology.

[189]  G. Kahaly,et al.  Glycosaminoglycans in autoimmunity. , 1996, Clinical and experimental rheumatology.

[190]  C. Glass,et al.  Delineation of three different thyroid hormone-response elements in promoter of rat sarcoplasmic reticulum Ca2+ATPase gene. Demonstration that retinoid X receptor binds 5' to thyroid hormone receptor in response element 1. , 1994, The Journal of biological chemistry.

[191]  N. Lassen,et al.  Mechanisms of edema formation in myxedema--increased protein extravasation and relatively slow lymphatic drainage. , 1979, The New England journal of medicine.

[192]  I. Amende,et al.  The Metabolic and Cardiovascular Effects of Hyperthyroidism Are Largely Independent of β-Adrenergic Stimulation , 2004 .

[193]  J. Seidman,et al.  Modulation of atrial natriuretic factor by thyroid hormone: messenger ribonucleic acid and peptide levels in hypothyroid, euthyroid, and hyperthyroid rat atria and ventricles. , 1988, Endocrinology.

[194]  F. Sellke,et al.  The Direct Vasomotor Effect of Thyroid Hormones on Rat Skeletal Muscle Resistance Arteries , 1997, Anesthesia and analgesia.

[195]  I. Klein,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Regulation of Rat Cardiac Kv1.5 Gene Expression by Thyroid Hormone Is Rapid and Chamber Specific* , 2022 .

[196]  B. Gloss,et al.  The Thyroid Hormone Receptor-β-Selective Agonist GC-1 Differentially Affects Plasma Lipids and Cardiac Activity. , 2000, Endocrinology.

[197]  R. Erbel,et al.  Graves' disease and mitral valve prolapse , 1987 .

[198]  F. Ismail-Beigi,et al.  Thyroidal enhancement of rat myocardial Na,K-ATPase: Preferential expression of α2 activity and mRNA abundance , 1990, The Journal of Membrane Biology.

[199]  B. Müller,et al.  Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease , 2001, European journal of clinical investigation.

[200]  C. Sylvén,et al.  Evidence for the presence of functional thyrotropin receptor in cardiac muscle. , 1995, Biochemical and biophysical research communications.

[201]  M. Bettendorf,et al.  Transient Secondary Hypothyroidism in Children after Cardiac Surgery , 1997, Pediatric Research.

[202]  G. Kahaly,et al.  Cardiovascular hemodynamics and exercise tolerance in thyroid disease. , 2002, Thyroid : official journal of the American Thyroid Association.

[203]  A. Samarel,et al.  Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart. , 1996, Endocrinology.

[204]  J. Auer,et al.  Subclinical hyperthyroidism as a risk factor for atrial fibrillation. , 2001, American heart journal.

[205]  T. Visser,et al.  Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. , 2002, Endocrinology.

[206]  G. Williams,et al.  Cloning and Characterization of Two Novel Thyroid Hormone Receptor β Isoforms , 2000, Molecular and Cellular Biology.

[207]  F. B. Davis,et al.  Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. , 1999, The American journal of physiology.

[208]  C. Grohé,et al.  Single-channel activity and expression of atrial L-type Ca(2+) channels in patients with latent hyperthyroidism. , 2000, American journal of physiology. Heart and circulatory physiology.

[209]  M. Karmazyn,et al.  Intracellular sodium hydrogen exchange inhibition and clinical myocardial protection. , 2003, The Annals of thoracic surgery.

[210]  I. Grupp,et al.  Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts. , 1998, Circulation research.

[211]  J. Franklyn,et al.  Mortality after the treatment of hyperthyroidism with radioactive iodine. , 1998, The New England journal of medicine.

[212]  Frank Baas,et al.  Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor α1 , 1998, The EMBO journal.

[213]  V. Parsonnet,et al.  Impact of triiodothyronine on the survival of high-risk patients undergoing open heart surgery. , 1996, Cardiology.

[214]  F. Epstein,et al.  The molecular basis of thyroid hormone action. , 1994, The New England journal of medicine.

[215]  K. Ellenbogen,et al.  The management of atrial fibrillation. , 1996, The American journal of medicine.

[216]  F. B. Davis,et al.  Milrinone and thyroid hormone stimulate myocardial membrane Ca2+-ATPase activity and share structural homologies. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[217]  D. Rohrer,et al.  Thyroid hormone markedly increases the mRNA coding for sarcoplasmic reticulum Ca2+-ATPase in the rat heart. , 1988, The Journal of biological chemistry.

[218]  F. B. Davis,et al.  Acute cellular actions of thyroid hormone and myocardial function. , 1993, The Annals of thoracic surgery.

[219]  B. O'Neill,et al.  The effect of thyroid hormone therapy on angiographic coronary artery disease progression. , 1997, The Canadian journal of cardiology.

[220]  G. Kahaly,et al.  Prevalence of myxomatous mitral valve prolapse in patients with lymphocytic thyroiditis. , 1995, The American journal of cardiology.

[221]  G. Kahaly,et al.  [Cardiopulmonary involvement in thyroid gland diseases]. , 1996, Pneumologie.

[222]  D. Levy,et al.  Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. , 1998, Journal of the American College of Cardiology.

[223]  B. Weintraub,et al.  Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome". , 1991, The Annals of thoracic surgery.

[224]  K. Muntz Autoradiographic Characterization of-Adrenergic Receptor Subtpe in the Canine Conduction System , 2005 .

[225]  J S Child,et al.  Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. , 1998, The American journal of cardiology.

[226]  J. Romaldini,et al.  The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. , 2003, The Journal of clinical endocrinology and metabolism.

[227]  J. Franklyn,et al.  Thyroid status in patients after acute myocardial infarction. , 1984, Clinical science.

[228]  N. Zuhdi,et al.  Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. , 1990, Transplantation.

[229]  J. Harney,et al.  Chronic cardiac-specific thyrotoxicosis increases myocardial beta-adrenergic responsiveness. , 2004, Molecular endocrinology.

[230]  J. Samarut,et al.  Functional Interference between Thyroid Hormone Receptor α (TRα) and Natural Truncated TRΔα Isoforms in the Control of Intestine Development , 2001, Molecular and Cellular Biology.

[231]  É. Kiss,et al.  Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. , 1994, Circulation research.

[232]  I. Klein,et al.  Thyrotoxicosis and the heart. , 1998, Endocrinology and metabolism clinics of North America.

[233]  K. Wasserman Diagnosing cardiovascular and lung pathophysiology from exercise gas exchange. , 1997, Chest.

[234]  A. Burger,et al.  Differences between the effects of thyroxine and tetraiodothyroacetic acid on TSH suppression and cardiac hypertrophy. , 2001, European journal of endocrinology.

[235]  D. Kim,et al.  Effects of thyroid hormone on sodium pump sites, sodium content, and contractile responses to cardiac glycosides in cultured chick ventricular cells. , 1984, The Journal of clinical investigation.

[236]  B. Biondi,et al.  Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of beta-blockade. , 1995, The Journal of clinical endocrinology and metabolism.

[237]  W. Wiersinga,et al.  Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene. , 1998, Biochemical and biophysical research communications.

[238]  K. Ito,et al.  Management of atrial fibrillation in the post-thyrotoxic state. , 1982, The American journal of medicine.

[239]  J. Mehlsen,et al.  Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism. , 2002, Thyroid : official journal of the American Thyroid Association.

[240]  R. Jansson,et al.  Is a more active attitude warranted in patients with subclinical thyrotoxicosis? , 1990, Journal of internal medicine.

[241]  W. Dillmann Biochemical basis of thyroid hormone action in the heart. , 1990, The American journal of medicine.

[242]  A. Samarel,et al.  Hemodynamic regulation of myosin heavy chain gene expression. Studies in the transplanted rat heart. , 1992, The Journal of clinical investigation.

[243]  I. Klein,et al.  Thyroid hormone-regulated cardiac gene expression and cardiovascular disease. , 2002, Thyroid : official journal of the American Thyroid Association.

[244]  L. Sen,et al.  Acute effects of thyroid hormone on inward rectifier potassium channel currents in guinea pig ventricular myocytes. , 1996, Endocrinology.

[245]  R. Evans,et al.  The c-erb-A gene encodes a thyroid hormone receptor , 1986, Nature.

[246]  M. Davies,et al.  The floppy mitral valve. Study of incidence, pathology, and complications in surgical, necropsy, and forensic material. , 1978, British heart journal.

[247]  A. Toft Clinical practice. Subclinical hyperthyroidism. , 2001, The New England journal of medicine.

[248]  G. Rosenthal,et al.  Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease. , 2000, The Journal of thoracic and cardiovascular surgery.

[249]  R. D'Agostino,et al.  Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. , 1994, The New England journal of medicine.

[250]  L. Brunton,et al.  Increased myocardial beta-receptors and adrenergic responses in hyperthyroid pigs. , 1987, The American journal of physiology.

[251]  A. Burger,et al.  Organ-specific effects of 3,5,3'-triiodothyroacetic acid in rats. , 1997, European journal of endocrinology.

[252]  G. Kahaly,et al.  TSH receptor in endocrine autoimmunity. , 1996, Clinical and experimental rheumatology.

[253]  N. Bagchi,et al.  Effect of amiodarone on rat heart myosin isoenzymes. , 1987, Circulation research.

[254]  S. Mariotti,et al.  Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. , 2000, The Journal of clinical endocrinology and metabolism.

[255]  G. Kahaly,et al.  Cardiovascular and atherogenic aspects of subclinical hypothyroidism. , 2000, Thyroid : official journal of the American Thyroid Association.

[256]  J. Staffurth,et al.  Arterial embolism in thyrotoxicosis with atrial fibrillation. , 1977, British medical journal.

[257]  C. Kiefe,et al.  Cardiac systolic and diastolic function at rest and exercise in subclinical hypothyroidism: effect of thyroid hormone therapy. , 1996, Thyroid : official journal of the American Thyroid Association.

[258]  M. Sensel,et al.  Isolation and characterization of clones for the rat hepatic lipase gene upstream regulatory region. , 1990, Biochimica et biophysica acta.

[259]  J Clémenty,et al.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.

[260]  Irwin Klein,et al.  Hypothyroidism as a risk factor for cardiovascular disease , 2004, Endocrine.

[261]  N. Powe,et al.  Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. , 2000, The Journal of clinical endocrinology and metabolism.

[262]  W. Wiersinga,et al.  Amiodarone and thyroid hormone metabolism. , 1986, Postgraduate medical journal.

[263]  J. Samarut,et al.  Different functions for the thyroid hormone receptors TRα and TRβ in the control of thyroid hormone production and post‐natal development , 1999 .

[264]  D. Forrest,et al.  Functions of thyroid hormone receptors in mice. , 2000, Thyroid : official journal of the American Thyroid Association.

[265]  M. Bettendorf,et al.  Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study , 2000, The Lancet.

[266]  D. Kim,et al.  Effect of thyroid hormone on slow calcium channel function in cultured chick ventricular cells. , 1987, The Journal of clinical investigation.

[267]  J. Ratcliffe,et al.  Impaired action of thyroid hormone associated with smoking in women with hypothyroidism. , 1995, The New England journal of medicine.

[268]  J. Laragh,et al.  PLasma renin activity in syndromes of thyroid hormone excess and deficiency. , 1982, Life sciences.

[269]  F. B. Davis,et al.  Hyperthyroidism in patients over the age of 60 years. Clinical features in 85 patients. , 1974, Medicine.

[270]  G. Kahaly,et al.  Cardiac involvement in thyroid hormone resistance. , 2002, The Journal of clinical endocrinology and metabolism.